94 human histone peptides (H2A, H2B, H3, H4) carrying post-translational modifications (PTMs) immobilized in an ELISA plate. As histones are a major focus of epigenetics,creative peptides’s computational scientists compiled a unique library of synthetic post-translationally modified and unmodified human histone peptides that is now available as Peptide ELISA for the first time. The Histone Peptide ELISA displays 94 20mer peptides from Histones H2A, H2B, H3 and H4. Peptides carry PTMs at reported sites (e.g. acetylation, methylation, phosphorylation, citrullination...) in various combinations. Two control wells are included: 1 x FLAG-Peptide and 1x empty well.
CAT No: PE001
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Myotropic activity of allatostatins in tenebrionid beetles
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More